BY Charles Haynes, J.D.

In 2006, frustrated by the lack of research and treatment options for patients with ependymoma, Mark Gilbert, M.D., deputy chair of the Department of Neuro-Oncology at MD Anderson, proposed  creating an international group to develop new treatments for this rare type of brain tumor.

Under Gilbert's guidance, the Collaborative Ependymoma Research Network (CERN) Foundation was established with the mission of developing new...